Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.64)
# 814
Out of 5,102 analysts
137
Total ratings
55.22%
Success rate
4.56%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $3.94 | +204.57% | 1 | Nov 12, 2025 | |
| HCA HCA Healthcare | Maintains: Outperform | $400 → $500 | $482.35 | +3.66% | 12 | Oct 27, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $31.17 | -3.75% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $429.16 | +35.15% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $336.73 | -3.48% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $40.46 | +6.28% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $266.49 | +16.33% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $272.26 | +37.74% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.62 | +57.48% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $29.51 | +25.38% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $174.15 | -3.53% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $114.36 | +26.79% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $33.38 | +19.83% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.28 | +52.44% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $9.59 | - | 2 | Mar 7, 2024 |
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $3.94
Upside: +204.57%
HCA Healthcare
Oct 27, 2025
Maintains: Outperform
Price Target: $400 → $500
Current: $482.35
Upside: +3.66%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $31.17
Upside: -3.75%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $429.16
Upside: +35.15%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $336.73
Upside: -3.48%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $40.46
Upside: +6.28%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $266.49
Upside: +16.33%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $272.26
Upside: +37.74%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.62
Upside: +57.48%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $29.51
Upside: +25.38%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $174.15
Upside: -3.53%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $114.36
Upside: +26.79%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $33.38
Upside: +19.83%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.28
Upside: +52.44%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.59
Upside: -